History of formation

Today  "InterChem" is a modern, high-tech company, one of the leaders of the pharmaceutical market of Ukraine. In the beginning of 1990’s when the founders of “InterChem” were the postgraduate students at A.V. Bogatskiy Physico-Chemical Institute of the Academy of Sciences of the Ukrainian Soviet Socialist Republic they could not even dream of such. The company was started from the dream of young scientists.  And today our company is a part of TOP-10 national producers of medicines and TOP-20 of all producers represented in the Ukrainian pharmaceutical market.

Foundation of the Open Joint-Stock Company “Joint Ukrainian-Belgian Chemical Enterprises “InterChem”.

The start of the production of the active pharmaceutical ingredients and chemicals.

The first business contracts were signed for the export of the goods to Switzerland, France and Belgium.

Industrial production of the API Amixin started. The first pharmacy of “InterChem” was opened in Odessa.

The construction of the production unit for the manufacture of the medicines was launched. The plant was built from the “zero cycle” with the compliance of the rules of Good Manufacture Practice (GMP).

The production area for the manufacture of the medicines was put into operation.

 
In August, 2003 the first tablet was produced – batch No 0010803.

Company “InterChem” was recognized the winner of the IV Ukrainian national contest “The best employer of the Year”.

The opening of the scientific-research technological laboratory “Formulab” founded jointly with the company “MEGGLE”, Germany.

The domestic medicine “Amixin® IC” was promoted to the market.

The second medicines manufacturing line was put into operation. Certification of the medicines production on the compliance of the GMP requirements was arranged.

As a result of the Ukrainian national contest of the pharmaceutical sector “Panacea – 2008” “Amixin® IC” was recognized “The Medicine of Year” in the category of the over-the-counter drugs.

“InterChem” was recognized “The Company of the Year” (“Panacea-2009”)

The building of the hostel for the young employees was finished. Dr. Anatoliy Reder, General Director of “InterChem SLC”, with the co-authors was awarded with the Prize of the National Academy of Sciences of Ukraine named after A.I. Kiprianov “For the outstanding scientific papers in the branch of the organic chemistry, chemistry of high-molecular compounds and chemical technology” for the cycle of papers “Soporific and anxiolytic agent Levana (cinazepam). Development, properties, innovation”.

“Panacea-2011”: “InterChem SLC” is the most dynamically growing national drugs manufacturer”.

The Company was awarded with the prize of the winner of the Odessa regional round of the Ukrainian national rating “Honest Taxpayer-2011” in the medicinal branch.

As a result of the Ukrainian national contest of the pharmaceutical sector “Panacea – 2011” “Amixin® IC” was recognized “The Medicine of Year” in the category of the over-the-counter drugs in the second time.

The construction of the new industrial laboratory complex was started. On January 19, 2013 the “First Pile” holiday was arranged.

The innovative drug “Levana® IC” was recognized a laureate of the Ukrainian national contest of the goods quality “100 Best Goods of Ukraine”.

For the first time in Ukraine "InterСhem" registered morphine tablets production.

As a result of the Ukrainian national contest of the pharmaceutical sector “Panacea – 2013” “Amixin® IC” again was recognized “The Medicine of Year” in the category of the over-the-counter drugs in the third time. In the category “Prescription drugs” "Gidazepam ІC ®" also won.

In September 2013, Department of production of the finished drugs celebrated its 10 years anniversary. 

2015
General Director of SLC "InterChem" Anatoly Reder was awarded the title of honorary professor ONU named after Mechnikov.

"InterChem" recognized as "The leader of the industry - 2015" by the results of the National Business Rating by sum of the financial and economic activity rate, as well as in the category "Investment attractiveness".